Tres Cantos, Spain

Amira Rudi

This inventor holds 1 USPTO granted patent. Top assignee: Instituto Biomar, S.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amira Rudi. Retrieved from https://idiyas.com/inventor/amira-rudi-2f0mluzz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amira Rudi: Innovator in Cytotoxic Alkaloid Derivatives

Introduction

Amira Rudi is a prominent inventor based in Tres Cantos, Spain. She has made significant contributions to the field of biochemistry, particularly in the discovery of novel cytotoxic alkaloid derivatives. Her work has implications for the development of new therapeutic agents.

Latest Patents

Amira Rudi holds a patent for her work titled "Cytotoxic alkaloid derivatives including Asmarine A and B isolated from a sponge." This patent discloses the compounds Asamarine A and B, which are novel cytotoxic diterpene-alkaloids isolated from the sponge Raspailia sp. The structures of these compounds have been established based on NMR data and confirmed by X-ray analysis. The patent also describes various compounds with specific structural characteristics, including different alkyl and alkanoyl groups.

Career Highlights

Amira Rudi is associated with Instituto Biomar, S.A., where she continues her research and development efforts. Her innovative work in isolating and characterizing cytotoxic compounds has positioned her as a key figure in her field.

Collaborations

Amira collaborates with notable colleagues, including Yoel Kashman and Tesfamariam Yosief. Their combined expertise enhances the research output and fosters a collaborative environment for innovation.

Conclusion

Amira Rudi's contributions to the field of biochemistry through her patent on cytotoxic alkaloid derivatives highlight her role as an influential inventor. Her work not only advances scientific knowledge but also opens new avenues for therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…